Imagine trying to find out how much sugar dissolves in a cup of tea, but you have to do it for thousands of different chemicals. Usually, this is either a fast guess or a slow, expensive process that wastes a lot of material. This technology uses special laser light to get the exact answer almost instantly while using tiny amounts of chemicals.
Current solubility testing is a bottleneck in drug discovery because it is either fast but inaccurate, or accurate but slow and wasteful of expensive chemicals.
A prototype solubility measurement instrument based on high-efficiency second harmonic scattering (SHS) and a benchmarking system against HPLC.
If you are a drug discovery firm dealing with slow early-stage screening and high material waste — this project developed an optical measurement instrument that reduces testing time and costs by 90% and chemical consumption by 99%.
If you are a CDMO dealing with resource-intensive formulation chemistry — this project developed a non-destructive solubility tool that cuts electricity use by 97% and requires 80% fewer compounds.
If you are a chemical producer dealing with the high cost of standard solubility tests — this project developed a high-efficiency scattering system that reduces measurement costs by 90%.
The technology is designed to reduce testing costs by 90% compared to current gold-standard methods.
Yes, the project aims to develop a robust demonstrator instrument and a go-to-market strategy via a dedicated startup for industrial deployment.
Based on available project data, a dedicated startup is leading the commercialization and development of the business model.
Yes, it contributes to the European Green Deal by reducing chemical consumption by 99% and energy use by 97%.
The project period runs from June 1, 2024, to November 30, 2026, focusing on developing a demonstrator and validating it with early adopters.
The consortium is strategically balanced for commercialization, featuring a 25% industry ratio with 2 SMEs and 1 industry partner. It combines the commercial drive of a startup with the technical validation of a European research infrastructure (EU-OPENSCREEN ERIC), a technology center, and a pharmaceutical research institute, ensuring the product is tested against real-world pharma needs.
Contact EU-OPENSCREEN ERIC in Germany
Contact us to connect with the FASS startup for early adopter validation.
